| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratoire de Virologie Moléculaire de l'INSERM, Lille, France
Virology Division, National Institute for Medical Research, Mill Hill, London NW7 1AA, England
Protein IX from adenovirus type 2 was purified by two methods, one from groups of nine hexons obtained by disrupting purified virus by heating in the presence of deoxycholate, and the other by a previously published method. The purified protein was used to obtain a monospecific antiserum. Protein IX was found to possess both sub-group- and type-specific antigenic determinants which were apparently accessible within the groups of nine hexons. Approximately 15 molecules of IX were found per group of nine hexons and from considerations of symmetry it seemed possible that IX was located at the ‘corner to edge’ contacts between hexons in the icosahedron.
The protein in infected cells was found to possess approximately neutral charge as determined by immunoelectrophoresis. This was consistent with the amino acid composition, which showed it to be rich in serine, alanine and leucine with approximately half of its glutamic and aspartic acid residues amidified, and the isoelectric point of 6.0, as determined by two dimensional gel analysis. No free N-terminal amino acid was detectable. It is suggested that a unique tryptophan residue is located at around position 70 from the blocked N-terminus, on the basis of chemical cleavage by BNPS-skatole. Based on one tryptophan residue a total of 107 amino acids and a mol. wt. of 11200 was deduced. Analysis of 35S-methionine-labelled infected cell extracts in a two-dimensional gel system showed that the synthesis of polypeptide IX could be detected early in infection, i.e. in the presence of an inhibitor of DNA synthesis.
* Author to whom reprint requests should be addressed.
Received 30 October 1978;
accepted 21 March 1979.
This article has been cited by other articles:
|
|
 |
|
  M. P. Marsh, S. K. Campos, M. L. Baker, C. Y. Chen, W. Chiu, and M. A. Barry Cryoelectron Microscopy of Protein IX-Modified Adenoviruses Suggests a New Position for the C Terminus of Protein IX J. Virol., December 1, 2006; 80(23): 11881 - 11886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Bauer, G. Flunker, K. Bruss, K. Kallwellis, H. Liebermann, T. Luettich, M. Motz, and W. Seidel Detection of Antibodies against Adenovirus Protein IX, Fiber, and Hexon in Human Sera by Immunoblot Assay J. Clin. Microbiol., September 1, 2005; 43(9): 4426 - 4433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vellinga, S. Van der Heijdt, and R. C. Hoeben The adenovirus capsid: major progress in minor proteins J. Gen. Virol., June 1, 2005; 86(6): 1581 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Sargent, R. A. Meulenbroek, and R. J. Parks Activation of Adenoviral Gene Expression by Protein IX Is Not Required for Efficient Virus Replication J. Virol., May 15, 2004; 78(10): 5032 - 5037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vellinga, M. J. W. E. Rabelink, S. J. Cramer, D. J. M. van den Wollenberg, H. Van der Meulen, K. N. Leppard, F. J. Fallaux, and R. C. Hoeben Spacers Increase the Accessibility of Peptide Ligands Linked to the Carboxyl Terminus of Adenovirus Minor Capsid Protein IX J. Virol., April 1, 2004; 78(7): 3470 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bertolotti-Ciarlet, S. E. Crawford, A. M. Hutson, and M. K. Estes The 3' End of Norwalk Virus mRNA Contains Determinants That Regulate the Expression and Stability of the Viral Capsid Protein VP1: a Novel Function for the VP2 Protein J. Virol., November 1, 2003; 77(21): 11603 - 11615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. P. Dmitriev, E. A. Kashentseva, and D. T. Curiel Engineering of Adenovirus Vectors Containing Heterologous Peptide Sequences in the C Terminus of Capsid Protein IX J. Virol., June 14, 2002; 76(14): 6893 - 6899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Molinier-Frenkel, R. Lengagne, F. Gaden, S.-S. Hong, J. Choppin, H. Gahery-Segard, P. Boulanger, and J.-G. Guillet Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response J. Virol., January 1, 2002; 76(1): 127 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rosa-Calatrava, L. Grave, F. Puvion-Dutilleul, B. Chatton, and C. Kedinger Functional Analysis of Adenovirus Protein IX Identifies Domains Involved in Capsid Stability, Transcriptional Activity, and Nuclear Reorganization J. Virol., August 1, 2001; 75(15): 7131 - 7141. [Abstract] [Full Text]
|
|
|
|
|
|
A. Akalu, H. Liebermann, U. Bauer, H. Granzow, and W. Seidel The Subgenus-Specific C-Terminal Region of Protein IX Is Located on the Surface of the Adenovirus Capsid J. Virol., July 1, 1999; 73(7): 6182 - 6187. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
